Reaction
Skin Depigmentation reporting signals
As of the last recalculation, Skin Depigmentation appears in 1,341 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is PAZOPANIB HYDROCHLORIDE (PRR 26.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pazopanib Hydrochloride | 45 | 26.7 | 26.7 |
| Minocycline | 13 | 17.5 | 17.5 |
| Avapritinib | 12 | 15.5 | 15.5 |
| Ribociclib | 29 | 14.6 | 14.6 |
| Nitrofurantoin | 13 | 12.3 | 12.4 |
| Nitrofurantoin (Monohydrate/Macrocrystals) | 13 | 12.2 | 12.2 |
| Crisaborole | 7 | 11.4 | 11.4 |
| Clobetasol Propionate Ointment Usp, 0.05% | 7 | 10.6 | 10.6 |
| Sunitinib Malate | 17 | 6.8 | 6.8 |
| Dupilumab | 170 | 6.1 | 6.1 |
| Secukinumab | 61 | 6.1 | 6.1 |
| Dabrafenib | 8 | 5.9 | 5.9 |
| Cabozantinib | 18 | 5.9 | 5.9 |
| Voclosporin | 3 | 5.4 | 5.4 |
| Vemurafenib | 4 | 5.2 | 5.2 |
| Voxelotor | 3 | 2.1 | 2.1 |
| Adapalene | 3 | 0.3 | 0.3 |